Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre-specified patient subgroups in the Effisayil 1 study.

Experimental dermatology·2023
Same author

Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT).

The British journal of dermatology·2021
Same author

Psoriasis, COVID-19 and shielding.

The British journal of dermatology·2021
Same author

Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non-biologic systemic therapies.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis.

The British journal of dermatology·2020

Related Experiment Videos

Psoriasis: advances in pathophysiology and management.

A MacDonald1, A D Burden

  • 1Alan Lyell Dermatology Centre, Western Infirmary, Glasgow, G11 6NT, UK. alisonmacdonald21@doctors.org.uk

Postgraduate Medical Journal
|November 9, 2007
PubMed
Summary

Psoriasis is a persistent inflammatory skin condition impacting daily life. Recent research advances understanding and leads to new targeted treatments for better patient management.

Area of Science:

  • Dermatology
  • Immunology
  • Psychology

Background:

  • Psoriasis affects 1-3% of Caucasians, causing persistent, disfiguring, and stigmatizing skin inflammation.
  • The disease's severity varies, significantly impacting daily activities and social interactions even with limited body surface area involvement.
  • Many patients express dissatisfaction with current management, highlighting the need for improved therapeutic options.

Purpose of the Study:

  • To address the psychological burden associated with psoriasis.
  • To develop more effective treatments for psoriasis.
  • To advance the understanding of psoriasis immunopathogenesis.

Main Methods:

  • Intense investigation into the immunopathogenesis of psoriasis.
  • Development of novel, targeted biological treatments for psoriasis.

Related Experiment Videos

Main Results:

  • Improved understanding of the underlying mechanisms of psoriasis.
  • Successful development of new targeted biological therapies.

Conclusions:

  • Recent advancements have significantly improved the understanding and treatment of psoriasis.
  • Targeted biological treatments offer new hope for patients dissatisfied with existing management.
  • Further research continues to refine therapeutic strategies for this chronic inflammatory skin disease.